GRUSF
Price
$0.43
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
106.75M
TSNDF
Price
$0.85
Change
+$0.10 (+13.33%)
Updated
Sep 5 closing price
Capitalization
264.18M
73 days until earnings call
Interact to see
Advertisement

GRUSF vs TSNDF

Header iconGRUSF vs TSNDF Comparison
Open Charts GRUSF vs TSNDFBanner chart's image
Grown Rogue International
Price$0.43
Change-$0.00 (-0.00%)
Volume$175.82K
Capitalization106.75M
TerrAscend
Price$0.85
Change+$0.10 (+13.33%)
Volume$676.24K
Capitalization264.18M
GRUSF vs TSNDF Comparison Chart in %
Loading...
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRUSF vs. TSNDF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRUSF is a Hold and TSNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GRUSF: $0.43 vs. TSNDF: $0.85)
Brand notoriety: GRUSF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GRUSF: 91% vs. TSNDF: 89%
Market capitalization -- GRUSF: $106.75M vs. TSNDF: $264.18M
GRUSF [@Pharmaceuticals: Generic] is valued at $106.75M. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $264.18M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRUSF’s FA Score shows that 0 FA rating(s) are green whileTSNDF’s FA Score has 1 green FA rating(s).

  • GRUSF’s FA Score: 0 green, 5 red.
  • TSNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, TSNDF is a better buy in the long-term than GRUSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRUSF’s TA Score shows that 2 TA indicator(s) are bullish while TSNDF’s TA Score has 4 bullish TA indicator(s).

  • GRUSF’s TA Score: 2 bullish, 6 bearish.
  • TSNDF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TSNDF is a better buy in the short-term than GRUSF.

Price Growth

GRUSF (@Pharmaceuticals: Generic) experienced а -4.34% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was -26.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

TSNDF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSNDF($264M) has a higher market cap than GRUSF($107M). TSNDF has higher P/E ratio than GRUSF: TSNDF (85.07) vs GRUSF (21.28). TSNDF YTD gains are higher at: 30.877 vs. GRUSF (-34.965). TSNDF has higher annual earnings (EBITDA): 11.3M vs. GRUSF (10.2M). TSNDF has more cash in the bank: 27.7M vs. GRUSF (9.25M). GRUSF has less debt than TSNDF: GRUSF (13.2M) vs TSNDF (242M). TSNDF has higher revenues than GRUSF: TSNDF (300M) vs GRUSF (23.8M).
GRUSFTSNDFGRUSF / TSNDF
Capitalization107M264M41%
EBITDA10.2M11.3M90%
Gain YTD-34.96530.877-113%
P/E Ratio21.2885.0725%
Revenue23.8M300M8%
Total Cash9.25M27.7M33%
Total Debt13.2M242M5%
FUNDAMENTALS RATINGS
GRUSF vs TSNDF: Fundamental Ratings
GRUSF
TSNDF
OUTLOOK RATING
1..100
8421
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
5398
PRICE GROWTH RATING
1..100
5635
P/E GROWTH RATING
1..100
658
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRUSF's Valuation (61) in the null industry is in the same range as TSNDF (77). This means that GRUSF’s stock grew similarly to TSNDF’s over the last 12 months.

GRUSF's Profit vs Risk Rating (59) in the null industry is somewhat better than the same rating for TSNDF (100). This means that GRUSF’s stock grew somewhat faster than TSNDF’s over the last 12 months.

GRUSF's SMR Rating (53) in the null industry is somewhat better than the same rating for TSNDF (98). This means that GRUSF’s stock grew somewhat faster than TSNDF’s over the last 12 months.

TSNDF's Price Growth Rating (35) in the null industry is in the same range as GRUSF (56). This means that TSNDF’s stock grew similarly to GRUSF’s over the last 12 months.

TSNDF's P/E Growth Rating (8) in the null industry is somewhat better than the same rating for GRUSF (65). This means that TSNDF’s stock grew somewhat faster than GRUSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRUSFTSNDF
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARUIX11.97N/A
N/A
ARGA Value Institutional
VVOAX23.11N/A
N/A
Invesco Value Opportunities A
SXPRX53.24N/A
N/A
DWS S&P 500 Index R6
LFGCX39.41N/A
N/A
Lord Abbett Focused Growth C
MNBWX20.68N/A
N/A
Manning & Napier Pro-Blend Extnd Term W

GRUSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRUSF has been loosely correlated with GLASF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GRUSF jumps, then GLASF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRUSF
1D Price
Change %
GRUSF100%
-0.25%
GLASF - GRUSF
34%
Loosely correlated
+3.99%
TSNDF - GRUSF
33%
Poorly correlated
+13.08%
TCNNF - GRUSF
29%
Poorly correlated
+4.55%
VRNOF - GRUSF
29%
Poorly correlated
+5.51%
CURLF - GRUSF
28%
Poorly correlated
+1.79%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
+13.08%
GTBIF - TSNDF
78%
Closely correlated
+4.55%
CRLBF - TSNDF
76%
Closely correlated
+5.26%
TCNNF - TSNDF
76%
Closely correlated
+4.55%
CURLF - TSNDF
74%
Closely correlated
+1.79%
VRNOF - TSNDF
74%
Closely correlated
+5.51%
More